Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Board Changes

14 Mar 2025 07:00

RNS Number : 6440A
Rosslyn Data Technologies PLC
14 March 2025
 

14 March 2025

 

Rosslyn Data Technologies plc

("Rosslyn", the "Group" or the "Company")

 

Board Changes

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based enterprise spend intelligence platform, is pleased to announce the appointment of Dr John Chessher as an Independent Non-Executive Director with immediate effect. John will replace Ginny Warr who has informed the Company of her decision to step down as a Non-Executive Director of the Company due to increased commitments in her executive role. Ginny will step down from the Board on 31 March 2025.

 

John has 30 years' investment industry experience and has held CEO and director-level positions at leading asset management and investment banking firms. He has most notably previously acted as CEO of Cenkos Securities Asia and as Head of Asia Pacific Research at Schroder Investment Management. John is currently a Non-Executive Director of Sunda Energy plc, an AIM-listed exploration and appraisal company focussed on gas assets in Southeast Asia.

 

John is a CFA charter-holder, holds an MA in Engineering Science from Oxford University and DBA, MSc and MBA qualifications from Henley Business School.

 

Following his appointment, John will act as Chair of the Audit and Remuneration Committees.

 

James Appleby, Chairman of Rosslyn, said: "I am delighted to welcome John to the Board of Rosslyn. We look forward to working with him and benefitting from his significant corporate experience. I would also like to thank Ginny for her excellent contribution over the past few years and we wish her well for the future."

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/Camilla Hume/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

+44 (0)20 4582 3500

 

 

Further information on Dr John Chessher

 

John Robert Chessher (aged 62) has held the following directorships in the past 5 years:

 

Current Directorships

Previous Directorships held in the past 5 years

Sunda Energy plc

Mind Markets Limited

 

Dr John Chessher does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Dr John Chessher required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend intelligence platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKNBPCBKDDND
Date   Source Headline
23rd Mar 20215:54 pmRNSExercise of Options
4th Mar 20217:00 amRNSChange of auditor
12th Jan 20217:00 amRNSHalf-year Report
21st Dec 20207:00 amRNSLaunch of CustomsCloudTM product
11th Nov 20207:00 amRNSContract Win
29th Oct 20204:45 pmRNSResult of AGM
30th Sep 20209:20 amRNSNotice of AGM
29th Sep 202010:15 amRNSHolding(s) in Company
28th Sep 20204:33 pmRNSChange of Registered Office
25th Sep 202012:01 pmRNSIssue of Equity
24th Sep 20207:00 amRNSDirector/PDMR Dealing
22nd Sep 20207:00 amRNSAudited Results for the year ended 30 April 2020
1st Sep 20207:00 amRNSBoard Update
28th Aug 20204:42 pmRNSHolding(s) in Company
17th Aug 20207:00 amRNSAppointment of Chief Customer Officer
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:01 amRNSPrice Monitoring Extension
7th Jul 20207:00 amRNSStrengthening client relationships during COVID-19
25th Jun 20207:00 amRNSContract Renewals
16th Jun 20209:01 amRNSDirector/PDMR Options
15th Jun 20207:00 amRNSGrant of Options
12th Jun 20204:13 pmRNSHolding(s) in Company
11th Jun 20203:07 pmRNSHolding(s) in Company
9th Jun 20208:40 amRNSHolding(s) in Company
2nd Jun 20208:07 amRNSHolding(s) in Company
1st Jun 20208:56 amRNSHolding(s) in Company
29th May 20209:43 amRNSHolding(s) in Company
29th May 20208:43 amRNSHolding(s) in Company
28th May 202012:32 pmRNSHolding(s) in Company
28th May 202010:39 amRNSHolding(s) in Company
27th May 202012:06 pmRNSResult of General Meeting
19th May 20208:19 amRNSHolding(s) in Company
18th May 20202:48 pmRNSHolding(s) in Company
15th May 20202:49 pmRNSHolding(s) in Company
7th May 20203:53 pmRNSPlacing to Raise £7.3m and Trading Update
10th Feb 202010:56 amRNSDirector/PDMR Shareholding
4th Feb 20205:26 pmRNSDirector/PDMR Shareholding
15th Jan 20209:17 amRNSPDMR Shareholding
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
14th Jan 20207:01 amRNSContract Win
14th Jan 20207:00 amRNSHalf-year Report
8th Jan 20207:00 amRNSContract Wins
11th Dec 20197:00 amRNSTrading Update
26th Nov 20198:57 amRNSHolding(s) in Company
25th Nov 20196:17 pmRNSDirector/PDMR Shareholding
17th Oct 20192:01 pmRNSResult of AGM
17th Oct 20197:00 amRNSBoard Changes
24th Sep 20197:00 amRNSAcquisition
17th Sep 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.